Yadanzioside K is primarily studied for its potential anti-cancer properties, particularly in inhibiting the growth of certain tumor cells. It has shown activity in inducing apoptosis and suppressing proliferation in liver and breast cancer cell lines. Research also suggests it may modulate signaling pathways involved in inflammation and cell survival, making it a compound of interest in oncology and pharmacological research. Due to its natural origin and structural complexity, it is used as a reference compound in the development of novel chemotherapeutic agents and in structure-activity relationship studies. Its application remains mainly in preclinical research and drug discovery.